Assignee
VIRTTU BIOLOGICS LTD
GB·2 granted patents·5 pending applications·0 citations·filing 2015–2020
Top patents by PatentIndex Score
7 records- 0163US10813958B2Use of oncolytic herpes simplex virus, alone or in combination with immune check-point inhibitor, in the treatment of cancerVIRTTU BIOLOGICS LTD·Filed 2018·Granted Oct 27, 2020·0 cites·10 claims
- 0260US2020078426A1Treatment of cancer by infusion of oncolytic herpes simplex virus to the bloodVIRTTU BIOLOGICS LTD·Filed 2019·Application pending·0 cites
- 0360US2021169955A1Use of Oncolytic Herpes Simplex Virus, Alone or in Combination with Immune Check-Point Inhibitor, in the Treatment of CancerVIRTTU BIOLOGICS LTD·Filed 2020·Application pending·0 cites
- 0440US10596210B2Oncolytic herpes simplex virus infected cellsVIRTTU BIOLOGICS LTD·Filed 2016·Granted Mar 24, 2020·0 cites·14 claims
- 0540US2020000861A1Treatment of cancerVIRTTU BIOLOGICS LTD·Filed 2019·Application pending·0 cites
- 0635US2017071991A1Oncolytic Virus and Aurora Kinase Inhibitor for the Treatment of CancerVIRTTU BIOLOGICS LTD·Filed 2015·Application pending·0 cites
- 0732US2017319638A1Treatment of cancerVIRTTU BIOLOGICS LTD·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when VIRTTU BIOLOGICS LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →